CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Total
Balance at beginning of period at Dec. 31, 2023	$ 1	$ 928,080	$ (106)	$ (770,796)	$ 157,179
Balance at beginning of period (in shares) at Dec. 31, 2023	70,894,889
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(55)			(55)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	353,128
Unrealized gain on marketable securities			(258)		(258)
Stock-based compensation expense		2,089			2,089
Net loss				(16,941)	(16,941)
Balance at end of period at Mar. 31, 2024	$ 1	930,114	(364)	(787,737)	142,014
Balance at end of period (in shares) at Mar. 31, 2024	71,248,017
Balance at beginning of period at Dec. 31, 2024	$ 1	1,058,317	97	(902,861)	$ 155,554
Balance at beginning of period (in shares) at Dec. 31, 2024	107,850,124				107,850,124
Increase (Decrease) in Stockholders' Equity
Issuance of common stock in connection with vesting of restricted stock units		(275)			$ (275)
Issuance of common stock in connection with vesting of restricted stock units (in shares)	415,405
Unrealized gain on marketable securities			337		337
Stock-based compensation expense		3,535			3,535
Net loss				(15,085)	(15,085)
Balance at end of period at Mar. 31, 2025	$ 1	$ 1,061,577	$ 434	$ (917,946)	$ 144,066
Balance at end of period (in shares) at Mar. 31, 2025	108,265,529				108,265,529